All news from Nuclear Medicine

Nuclear medicine

PET Scans Important in Assessing Some Forms of Lymphoma

Lymphomas are cancers of the immune system. They are broadly classified into Hodgkin lymphoma and non-Hodgkin lymphoma. Each of those categories also has several different subtypes. PET scans are an important part of care planning and management for certain types of lymphoma. The scans can help determine cancer stage, treatment response and patient prognosis. They also help direct…

Nuclear medicine

Technique to Clear Abnormal Tau Protein from Human Neurons

Harnessing a probe used to image the brain in diagnosing Alzheimer’s disease and related forms of dementia; scientists at Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) have successfully cleared patient-derived brain cells of an abnormal protein associated with dementia and other neurogenerative disorders. The findings; reported in the journal eLife; provide a new tool to…

Nuclear medicine

Trends In Medical Imaging Technology

Medical Imaging is one of the most innovative and dynamic fields in the healthcare industry. It is crucial for disease diagnosis and has advanced remarkably over the last few years with widespread adoption of imaging systems like MRI, CT & USG and various modifications of these technologies. Some of the new trends in the medical…

Nuclear medicine

NHS Patients Have Cancer Scans Cancelled After Supplier Problems

Concerns have been raised that problems related to the supply of a substance used to screen for cancerous cells is causing delays for NHS patients in England, with many exposed to repeated cancellation of scans at short notice. Choline is a radiotracer injected into patients an hour before PET-CT scans, predominately when patients are feared to…

Nuclear medicine

SRMC Launches Newest 3D PET/CT Scanner

A regional leader in advanced medical imaging, Salem Regional Medical Center (SRMC) ; is now offering the next-generation 3D PET/CT scanner with the fastest and highest image quality available anywhere in the nation. Therefore The new 3D PET/CT scanner will be used to diagnose cancers; monitor cancer treatment; and detect cancer recurrence. Therefore “Salem Regional…

Nuclear medicine

Nuclear Medicine, Radiation Oncology Get Major Uplift

Over 500 more patients a year will now be able to get vital medical examines thanks to a new nuclear imaging machine now up and running in Bangladesh through IAEA support. The machine is an essential tool for advanced nuclear medicine diagnosis of health conditions, such as cardiovascular diseases and cancer. Cardiovascular diseases “Waiting in…

Nuclear Medicine

Sidra Medicine Launchs Nuclear Medicine Therapeutic Service Soon

Sidra Medicine, a member of Qatar Foundation, will soon start providing nuclear medicine therapeutic service to inpatients; a senior official told Gulf Times. “So far, we have activated and opened our diagnostic nuclear medicine and molecular imaging services; and we are working hard to open the therapeutic service which should open within the next few…

Nuclear medicine

Study Demonstrates Clinical Impact of Amyloid PET Imaging

Amyloid PET imaging is a diagnostic technique that determines whether patients with memory complaints have amyloid plaques in the brain, an indicator of Alzheimer’s disease. It represents a potential major advance in the assessment of those with cognitive impairment. Before amyloid PET, these plaques could only be detect by examining the brain at autopsy. Memory…

Nuclear medicine

The Potential Benefits Of Total Body PET/CT Imaging

Case studies from the first total-body positron emission tomography/computed tomography (PET/CT) scanner reveal multiple benefits of the novel imaging technology, providing a solid groundwork upon which to build its clinical utility. Published in the March issue of The Journal of Nuclear Medicine, the case studies showed enhanced image quality; reduced scan time, a longer time window…

Nuclear medicine

Prognostic Role of Baseline 18F-FDG PET/CT Metabolic Parameters

Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT in treatment response evaluation and prediction of outcome are present. The aim of study was to investigate whether the metabolic PET/CT features may predict treatment evaluation and prognosis in MCL. We…

Nuclear medicine

Tumors Show Scientists Where Cancer Drugs Are Working

The technique uses PET imaging of a synthesized radiolabeled protein that locks on to tumor cells, letting researchers visually follow where a so-called checkpoint inhibitor drug binds to a tumor as it disperses. “This approach offers a vital step toward directly measuring how well immunotherapy drugs are able to engage a tumor in any given…

Nuclear medicine

Repurposing Drugs To Outsmart Cancers

A 56-year-old female patient presented to her gynecologist in February 2013 with a palpable lymph node in the right axilla. Bilateral mammograms and blood tumor markers are obtain. Mammograms identified bilateral lymphadenopathy. With the exception of an elevate carbohydrate antigen CA19-9, all other tumor markers were normal. Magnetic resonance imaging (MRI) of the abdomen and…